As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, ArQule will likely underperform.
Peter JD President, COO, Principal Financial Officer, General Counsel and Secretary
ArQule Price and Market Media
The median price of ArQule for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 2.85 with a coefficient of variation of 3.76. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 2.88, and mean deviation of 0.09. The Stock received some media coverage during the period.
ArQule Inc [ARQL] is traded on NASDAQ General Markets in USA. It is located in Woburn, MA and employs 97 people. The company currently falls under 'Small-Cap' category with current market capitalization of 178.53 M. ArQule Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 62.86 M outstanding shares of which 3.04 M shares are presently shorted by private and institutional investors with about 8.4 trading days to cover.
ArQule, Inc., a clinicalstage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory